The provision to exclude in vitro diagnostic method the suspected [challenge] acute coronary syndrome. Determination of the concentration of heart disease one marker, as well as be involved in determination of the concentration of D- dimer The invention relates to acute least to be selected in the sample, the myoglobin troponin, CK-MB and exclude in vitro diagnostic method the suspected coronary syndromes (ACS), and, in order to exclude in vitro diagnostics, and reagents for quantifying the concentration of the cardiac disease marker of the at least one suspected acute coronary syndrome D- the use of a reagent for quantifying the concentration of the dimer. None [Selection Figure]
展开▼